University of New Mexico Clinical and Translational Science Center
新墨西哥大学临床和转化科学中心
基本信息
- 批准号:9257477
- 负责人:
- 金额:$ 271.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-14 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:Center for Translational Science ActivitiesClinicalClinical InvestigatorClinical ResearchClinical SciencesCollaborationsCommunitiesCommunity PracticeCommunity of PracticeComplexDataDevelopmentDiagnosticDisciplineElementsFundingGeographyGoalsHealthHealth Care ResearchHealth SciencesHealth systemHealthcareHispanicsIndividualIndustryInformaticsInstitutesInstitutional PolicyInterventionLaboratoriesLeadLeadershipLearningLongevityMeasuresMedicalMethodsMinorityMissionNative AmericansNew MexicoOutcomePatientsPhasePlayPolicy DevelopmentsPopulationPopulation HeterogeneityPreventivePreventive InterventionProcessResearchResearch DesignResearch InfrastructureResearch MethodologyResearch PersonnelResource SharingResourcesRoleRuralScienceSiteSpeedStrategic PlanningTherapeuticTherapeutic InterventionTrainingTraining and EducationTranslatingTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesVisioncatalystclinical practiceethnic diversityimprovedinnovationinventionnamed groupnovel diagnosticspopulation healthracial and ethnicrural underservedsuccesssynergismtranslational scientist
项目摘要
Contact PD/PI: LARSON, RICHARD S
Our vision for the University of New Mexico Health Sciences Center (UNM) Clinical and Translational Science
Center (CTSC) is to be an essential part of tightly integrated networks. The resulting collective synergy will
catalyze transit of therapeutic, diagnostic, and preventive interventions; disseminate innovative translational
research methods and best practices; and lead informatics standards and policy development to promote
shared resources and clinical and translational research (CTR). We will accomplish this by providing tailored
resources to accelerate translation, which will be harmonized with other CTSA hubs, including for example:
multi-site study support, regulatory support, research design, workforce training, and integrated informatics
support. Our focus will be to advance the full spectrum of both clinical and translational research and science
(CTR/S). So that our impact is clearly demonstrated, we also propose meaningful, measureable goals and
outcomes. The UNM CTSC offers a unique setting to achieve this vision and to catalyze high quality CTR/S.
One of four majority-minority states, New Mexico is ethnically diverse (Anglo, Hispanic, Native American), rural,
and medically disenfranchised with health-disparate populations. Our state presents geographic, racial/ethnic,
and rural obstacles to health care and outcomes and is among only five of 24 IDeA states with a CTSA hub. A
key element of our CTSC is continuous improvement and learning in order to translate what we know into what
we do. In order to achieve this, we will continue to build and enhance synergy among new technological
capabilities, catalyze opportunities, and effect institutional policy change. Through the following five strategic
aims, we are poised to play a leadership role in our state and region while being a significant asset to and
partner in the CTSA consortium: 1) Align the governance, leadership, and strategic planning of the entire UNM
health system, its partners, and its academic enterprise with the CTSC and CTR/S; 2) Engage in beneficial
collaboration and partnerships; 3) Use our initial success in education and training to build the translational
workforce of tomorrow; 4) Develop and disseminate innovative and streamlined research resources (including
data and informatics), methods, and processes with a focus on quality and efficiency; 5) Integrate translational
science across its multiple phases and disciplines within complex populations and across the lifespan. With our
CTSC as the catalyst, our expected outcomes are to a) improve health through continuous input, innovation,
and learning; b) speed development and use of new diagnostics, therapeutics, preventive interventions; and c)
focus on complex and special populations in our state and region, including those that are rural, underserved,
and diverse across the continuum of lifespan.
Project Summary/Abstract Page 195
Contact PD/PI: LARSON, RICHARD S
Project Narrative
The mission of UNM CTSC is to improve quality and efficiency of clinical and translational research so
that new diagnostics, therapeutics, and preventive interventions are developed more rapidly. This will
result in better health, particularly among the diverse populations in New Mexico and the U.S.
联系PD/PI:Larson,Richard S
我们对新墨西哥大学健康科学中心(UNM)临床和转化科学的愿景
中心(CTSC)是紧密整合网络的重要组成部分。由此产生的集体协同作用将
催化治疗,诊断和预防性干预的过境;传播创新的翻译
研究方法和最佳实践;并领导信息标准和政策制定以促进
共享资源,临床和翻译研究(CTR)。我们将通过提供量身定制来实现这一目标
加速翻译的资源将与其他CTSA枢纽进行协调,包括:
多站点研究支持,监管支持,研究设计,劳动力培训和综合信息
支持。我们的重点是促进临床和转化研究和科学的全部范围
(CTR/S)。这样我们也明确证明了我们的影响,我们还提出了有意义的,测量的目标和
结果。 UNM CTSC提供了一个独特的设置,可实现这一愿景并催化高质量的CTR/S。
新墨西哥州的四个多数少数国家之一是种族上的潜水员(盎格鲁,西班牙裔,美国原住民),农村,
并以健康育儿人的人口剥夺了权利。我们的国家提出地理,种族/种族,
以及医疗保健和结果的粗糙障碍,是具有CTSA中心的24个想法状态中的五个。一个
我们CTSC的关键要素是持续的改进和学习,以便将我们所知道的内容转化为
我们做。为了实现这一目标,我们将继续在新技术中建立和增强协同作用
能力,催化机会并影响机构政策的变化。通过以下五个策略
目的,我们被毒死在我们的州和地区发挥领导作用,同时成为和
CTSA财团的合作伙伴:1)整合整个UNM的治理,领导和战略计划
卫生系统,其合作伙伴以及CTSC和CTR/S的学术企业; 2)从事有益的
协作与伙伴关系; 3)利用我们在教育和培训方面的最初成功来建立翻译
明天的劳动力; 4)开发和传播创新和简化的研究资源(包括
数据和信息),方法和过程,重点是质量和效率; 5)整合翻译
跨越复杂人群和整个寿命的多个阶段和学科的科学。与我们的
CTSC作为催化剂,我们的预期结果是a)通过连续的投入,创新,改善健康状况
和学习; b)速度开发和使用新的诊断,治疗,预防性干预措施;和c)
专注于我们州和地区的复杂和特殊人群,包括那些粗糙,服务不足的人群
和潜水员在整个寿命的连续体中。
项目摘要/摘要页面195
联系PD/PI:Larson,Richard S
项目叙述
CTSC的使命是提高临床和转化研究的质量和效率,因此
新的诊断,治疗和预防性干预措施更快地开发出来。这会
导致更好的健康,尤其是在新墨西哥州和美国的潜水员人口中
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD S LARSON其他文献
RICHARD S LARSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD S LARSON', 18)}}的其他基金
UNM HSC Clinical and Translational Science Center
新墨西哥大学 HSC 临床和转化科学中心
- 批准号:
10165853 - 财政年份:2015
- 资助金额:
$ 271.62万 - 项目类别:
UNM HSC Clinical and Translational Science Center
新墨西哥州 HSC 临床和转化科学中心
- 批准号:
10206291 - 财政年份:2015
- 资助金额:
$ 271.62万 - 项目类别:
Building Quality Assurance/Quality Control Capacity at the UNM HSC Clinical and Translational Science Center
在 UNM HSC 临床和转化科学中心建立质量保证/质量控制能力
- 批准号:
10381962 - 财政年份:2015
- 资助金额:
$ 271.62万 - 项目类别:
University of New Mexico Clinical and Translational Science Center
新墨西哥大学临床和转化科学中心
- 批准号:
9085848 - 财政年份:2015
- 资助金额:
$ 271.62万 - 项目类别:
UNIVERSITY OF NEW MEXICO CLINICAL AND TRANSLATIONAL SCIENCE CENTER
新墨西哥大学临床与转化科学中心
- 批准号:
8365130 - 财政年份:2011
- 资助金额:
$ 271.62万 - 项目类别:
相似国自然基金
老年重症新冠患者体内炎性细胞的特点、免疫致病机制及临床转归的研究
- 批准号:82370019
- 批准年份:2023
- 资助金额:65 万元
- 项目类别:面上项目
肝胆肿瘤治疗性溶瘤腺病毒疫苗的研制及其临床前应用性探索
- 批准号:82303776
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MUC5B/Siglec途径对RA-ILD巨噬细胞胞葬的作用机制及临床价值研究
- 批准号:82302605
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
AD谱系患者视网膜标记物偶联视觉神经环路的调控机制及其临床应用研究
- 批准号:82371437
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
结外鼻型NK/T细胞淋巴瘤免疫特征分析与临床转化研究
- 批准号:82370199
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 271.62万 - 项目类别:
Mentoring Diverse Early Career Researchers in Behavioral Diabetes Prevention Research
指导不同的早期职业研究人员进行行为糖尿病预防研究
- 批准号:
10794017 - 财政年份:2023
- 资助金额:
$ 271.62万 - 项目类别:
University of Florida Health Cancer Center Support Grant
佛罗里达大学健康癌症中心支持补助金
- 批准号:
10625750 - 财政年份:2023
- 资助金额:
$ 271.62万 - 项目类别: